Oxbridge Re Holdings Limited (NASDAQ:OXBR – Get Free Report) was the target of a large decline in short interest during the month of October. As of October 31st, there was short interest totalling 29,000 shares, a decline of 22.7% from the October 15th total of 37,500 shares. Based on an average trading volume of 16,500 shares, the days-to-cover ratio is presently 1.8 days. Currently, 0.6% of the shares of the stock are short sold.
Wall Street Analysts Forecast Growth
Separately, StockNews.com began coverage on shares of Oxbridge Re in a report on Wednesday. They issued a “hold” rating for the company.
Check Out Our Latest Report on OXBR
Oxbridge Re Price Performance
Institutional Inflows and Outflows
A hedge fund recently raised its stake in Oxbridge Re stock. Geode Capital Management LLC increased its holdings in shares of Oxbridge Re Holdings Limited (NASDAQ:OXBR – Free Report) by 3.3% in the third quarter, according to its most recent filing with the SEC. The fund owned 129,294 shares of the insurance provider’s stock after acquiring an additional 4,141 shares during the period. Geode Capital Management LLC owned about 2.14% of Oxbridge Re worth $359,000 at the end of the most recent quarter. 5.64% of the stock is owned by hedge funds and other institutional investors.
Oxbridge Re Company Profile
Oxbridge Re Holdings Limited, through its subsidiaries, provides specialty property and casualty reinsurance solutions. The company underwrites collateralized reinsurance contracts primarily for property and casualty insurance companies in the Gulf Coast region of the United States. It also issues reinsurance contracts through digital securities by blockchain technology.
Recommended Stories
- Five stocks we like better than Oxbridge Re
- How Can Investors Benefit From After-Hours Trading
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- The Basics of Support and Resistance
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Insider Trades May Not Tell You What You Think
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.